MAPT and Alzheimer disease: For instance, in Alzheimer’s disease, metabolic inflammation is associated with insulin resistance in the brain, which leads to impaired glucose metabolism and the subsequent accumulation of toxic amyloid-beta plaques and hyperphosphorylated tau proteins, which contributes to the neuronal dysfunction and cell death that characterizes this disease, bringing attention to the link between metabolic health and brain function.